Sign inGet started

Ros Matthew

Insider CIK 1673802 · VSTM Chief Operating Officer · EPZM See Remarks · UMRX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
COGT Cogent Biosciences, Inc. A Award deriv2026-06-092026-06-1117,901— $017,901SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2025-06-042025-06-0544,700— $044,700SEC↗
VSTM Verastem, Inc. A Award2025-04-012025-04-0350,000— $050,000SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2024-06-052024-06-1344,700— $044,700SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2024-01-022024-01-043,051— $03,051SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2023-10-022023-10-032,170— $02,170SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2023-07-032023-07-051,743— $01,743SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2023-06-072023-06-0836,700— $036,700SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2023-04-032023-04-041,900— $01,900SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2023-01-032023-01-041,792$7.19 $12.9K1,792SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2022-10-032022-10-041,419$9.08 $12.9K1,419SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2022-07-012022-07-052,194$5.87 $12.9K2,194SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2022-06-072022-06-0930,700— $030,700SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2022-04-012022-04-052,650$4.86 $12.9K2,650SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2022-01-032022-01-042,256$5.15 $11.6K2,256SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2021-10-012021-10-052,463$5.03 $12.4K2,463SEC↗
EPZM Epizyme, Inc. A Award deriv2021-08-162021-08-18134,178— $0134,178SEC↗
EPZM Epizyme, Inc. A Award2021-08-162021-08-1828,125— $0111,313SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2021-07-012021-07-062,225$4.78 $10.6K2,225SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2021-04-012021-04-052,068$5.66 $11.7K2,068SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2021-03-112021-03-1560,000— $060,000SEC↗
EPZM Epizyme, Inc. S Sale2021-02-042021-02-05894$11.21 $10.0K83,188SEC↗
EPZM Epizyme, Inc. A Award deriv2021-02-012021-02-02134,178— $0134,178SEC↗
EPZM Epizyme, Inc. A Award2021-02-012021-02-0228,125— $084,082SEC↗
EPZM Epizyme, Inc. S Sale2021-01-252021-01-272,872$11.41 $32.8K55,957SEC↗
COGT Cogent Biosciences, Inc. A Award deriv2021-01-042021-01-061,641— $01,641SEC↗
UMRX Unum Therapeutics Inc. A Award deriv2020-10-012020-10-029,247$1.35 $12.5K9,247SEC↗
UMRX Unum Therapeutics Inc. A Award deriv2020-07-012020-07-0635,280$0.31 $10.9K35,280SEC↗
EPZM Epizyme, Inc. S Sale2020-06-262020-06-302,728$16.15 $44.1K57,507SEC↗
EPZM Epizyme, Inc. A Award2020-06-252020-06-306,000— $060,235SEC↗
EPZM Epizyme, Inc. M Exercise deriv2020-06-182020-06-2268,651— $0104,787SEC↗
EPZM Epizyme, Inc. M Exercise deriv2020-06-182020-06-2241,063— $0110,557SEC↗
EPZM Epizyme, Inc. M Exercise deriv2020-06-182020-06-222,289— $0107,577SEC↗
EPZM Epizyme, Inc. S Sale2020-06-182020-06-2241,063$20.50 $841.8K51,798SEC↗
EPZM Epizyme, Inc. M Exercise2020-06-182020-06-2268,651$9.58 $657.7K120,449SEC↗
EPZM Epizyme, Inc. S Sale2020-06-182020-06-222,289$22.00 $50.4K51,798SEC↗
EPZM Epizyme, Inc. M Exercise2020-06-182020-06-222,289$12.45 $28.5K54,087SEC↗
EPZM Epizyme, Inc. M Exercise2020-06-182020-06-2241,063$9.12 $374.5K92,861SEC↗
EPZM Epizyme, Inc. S Sale2020-06-182020-06-2268,651$21.65 $1.49M51,798SEC↗
UMRX Unum Therapeutics Inc. A Award deriv2020-06-092020-06-1114,331— $014,331SEC↗
UMRX Unum Therapeutics Inc. A Award deriv2020-04-062020-04-0849,887$0.22 $11.0K49,887SEC↗
EPZM Epizyme, Inc. S Sale2020-03-252020-03-261,243$15.28 $19.0K51,798SEC↗
EPZM Epizyme, Inc. A Award2020-03-242020-06-304,000— $054,235SEC↗
EPZM Epizyme, Inc. A Award2020-03-242020-03-261,563— $053,041SEC↗
EPZM Epizyme, Inc. A Award deriv2020-02-032020-02-0556,213— $056,213SEC↗
EPZM Epizyme, Inc. A Award2020-02-032020-02-0511,688— $051,478SEC↗
EPZM Epizyme, Inc. F Tax w/h2020-01-242020-01-272,395$22.40 $53.6K39,790SEC↗
EPZM Epizyme, Inc. S Sale2020-01-242020-01-271,847$24.64 $45.5K42,185SEC↗
EPZM Epizyme, Inc. A Award2020-01-232020-01-275,000— $044,032SEC↗
UMRX Unum Therapeutics Inc. A Award deriv2020-01-022020-01-0624,274$0.45 $10.9K24,274SEC↗
UMRX Unum Therapeutics Inc. A Award deriv2019-10-012019-10-0312,509$0.88 $11.0K12,509SEC↗
UMRX Unum Therapeutics Inc. A Award deriv2019-07-262019-07-2928,661— $028,661SEC↗
EPZM Epizyme, Inc. S Sale2019-06-132019-06-141,185$12.10 $14.3K39,032SEC↗
EPZM Epizyme, Inc. A Award2019-06-122019-06-144,000— $040,217SEC↗
EPZM Epizyme, Inc. A Award deriv2019-01-242019-01-28151,620— $0151,620SEC↗
EPZM Epizyme, Inc. A Award2019-01-242019-01-2832,894— $036,217SEC↗
EPZM Epizyme, Inc. A Award deriv2018-02-092018-02-13106,344— $0106,344SEC↗
EPZM Epizyme, Inc. M Exercise deriv2018-02-052018-02-0672,264— $00SEC↗
EPZM Epizyme, Inc. S Sale2018-02-052018-02-06519$17.20 $8.9K2,603SEC↗
EPZM Epizyme, Inc. S Sale2018-02-052018-02-0671,745$16.63 $1.19M3,122SEC↗
EPZM Epizyme, Inc. M Exercise2018-02-052018-02-0672,264$9.58 $692.3K74,867SEC↗
EPZM Epizyme, Inc. A Award2017-02-282017-03-021,708$6.21 $10.6K1,708SEC↗
EPZM Epizyme, Inc. A Award deriv2017-02-082017-02-09109,866— $0109,866SEC↗
EPZM Epizyme, Inc. A Award deriv2016-05-162016-05-17173,438— $0173,438SEC↗